je.st
news
Tag: pharma
Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development Program
2016-01-11 22:08:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Acquisition Grows Mercks Oncology Pre-Clinical Pipeline with Novel IDO1 and TDO Inhibitors KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of innovative medicines for the treatment of cancer, with a particular emphasis on the fields of cancer immunotherapy and cancer metabolism. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: development
program
pharma
expands
Used IMA Pharma Liquid Bottle Filling Line - Ophthalmic
2016-01-11 12:44:45| chemicalonline Home Page
One (1) used IMA liquid bottle filling line consisting of the following: 1) IMA F940 monoblock filler/plugger/capper with stainless steel product contact surfaces capable holding up to 8 fill heads (currently set up for 6 fill heads).
Tags: line
liquid
bottle
filling
Big Pharma: Dealing With Fewer Biotech Targets
2016-01-01 00:50:16| Biotech - Topix.net
There have been 2,000-plus deals over the past two years in pharma and biotech, but the pace isn't likely sustainable The torrid pace of consolidation among drugmakers is bound to slow at some point. But that doesn't mean deal bankers and lawyers will be idle in 2016.
Tags: big
dealing
fewer
targets
Change in number of shares and votes in Moberg Pharma
2015-12-30 10:38:44| Appliances - Topix.net
STOCKHOLM, December 30, 2015. The number of shares and votes in Moberg Pharma AB has increased by 215,985 to 14,217,522 during December 2015.
Tags: number
change
votes
shares
Wolf of Pharma Street' Holds Up Unwelcome Mirror to Industry
2015-12-19 17:23:46| Biotech - Topix.net
Martin Shkreli, center, exits federal court in New York, on, Dec. 17. Shkreli was arrested on alleged securities fraud related to Retrophin Inc., a biotech firm he founded in 2011. Martin Shkreli, the pharmaceutical CEO arrested on securities fraud charges this week, may have made drug price increases notorious in the U.S. But his strategy of finding an old drug, raising its price, and taking the profit is one that's increasingly common among a new breed of drugmakers.
Tags: street
industry
holds
wolf
Sites : [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »